Plasmid News and Research

RSS

Review highlights emerging treatments for glioblastoma multiforme

A new research perspective was published in Volume 13 of Oncoscience on September 17, 2026, titled "Emerging pharmacological agents for glioblastoma multiforme: An update on active clinical trials (2025–2026)."

25 Sep 2026

Cannabis-derived nanovesicles showed early antitumor potential in mice

Researchers developed a Cannabis sativa hairy root culture system that produced stable plant-derived nanovesicles capable of promoting dendritic cell maturation and activating T-cell responses through TLR2- and TLR4-associated signaling. Oral administration also restored selected immune responses in immunosuppressed mice and suppressed tumor growth in an E.G7 lymphoma model, providing preliminary evidence for their immunomodulatory and antitumor potential.

15 Sep 2026

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

Discover how LumiPore improves intracellular delivery with gentle, high-efficiency transfection for drug discovery and cell therapy research.

From Trince 8 Sep 2026

The role of UV-Vis in biopharma QC

UV-Vis and fluorescence support faster QC of nucleic acid and protein concentration.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 20 Aug 2026

Galápagos wastewater is creating new reservoirs of antibiotic-resistant bacteria

Portable field surveillance reveals how untreated sewage is reshaping coastal microbial communities and spreading diverse resistance genes across one of the world’s most protected marine environments.

6 Aug 2026

Tire microplastics could fuel antibiotic resistance in urban environments

Tiny particles released as vehicle tires wear down may do more than pollute urban air, water, and soil. A new perspective article suggests that tire microplastics could create environmental hotspots that help antibiotic resistance genes persist, move between bacteria, and spread through cities.

29 Jul 2026

New genetic screening method unlocks insights into human development

A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides new insights into human development.

9 Jul 2026

Single DNA injection provides long-lasting weight loss in mouse study

Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can produce weight loss and blood glucose control in murine models that lasts up to 10 times as long as incretin-mimicking drugs like Ozempic and Wegovy.

26 Jun 2026

Quest Diagnostics study uncovers widespread community reservoirs of deadly gut bacterium

A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especially when it becomes multidrug-resistant and causes chronic urinary-tract infections (UTIs) in elderly women.

18 Jun 2026

Sino Biological’s Cell-Free Protein Synthesis supports Tencent AI for Life Sciences Lab’s protein design study published in Nature Communications

Sino Biological, Inc. has announced that its gene synthesis and cell-free protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature Communications, enabling rapid validation of AI-designed proteins with improved activity, stability, and multifunctionality

From Sino Biological Inc. 29 May 2026

Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit, accelerating AI-powered high-throughput antibody drug discovery

Sino Biological, Inc., a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.

From Sino Biological Inc. 20 May 2026

MIDAS platform accelerates protein engineering through rapid PCR-based screening

Proteins are critical to life – and to industry. There are countless proteins that could be engineered to treat and even cure serious diseases and cellular dysfunctions.

19 May 2026

4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK

4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic DNA for gene and cell therapies, mRNA vaccines, genome editing, or DNA vaccines.

From 4basebio PLC 6 May 2026

Addgene reinforces its expanding role in research with new brand

Addgene, a purpose-driven organization that joins with scientists around the world to reduce barriers to research and foster innovation, today announced that its strategic growth and expanded services have driven the organization’s refreshed brand.

29 Apr 2026

Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concerns

Researchers screened a phylogenetically diverse panel of alphacoronavirus spike proteins and found that a heart-nosed bat coronavirus from Kenya can use human CEACAM6 to enter cells.

23 Apr 2026

DNASE1L2 identified as a dynamic biomarker for TB progression

Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global population infected with Mycobacterium tuberculosis. While most infections remain latent (LTBI), individuals with LTBI are at risk of progressing to active TB and potentially becoming new sources of transmission.

31 Mar 2026

Novel microneedle patch accelerates healing of chronic diabetic wounds using light

Researchers from Nanjing Drum Tower Hospital, Southeast University, and Wenzhou Medical University have developed a novel microneedle patch that combines MXene hydrogel with nitric oxide (NO) and hypoxia-inducible factor-1α (HIF-1α) plasmid for enhanced diabetic wound treatment.

10 Mar 2026

Plasmid News and Research

Review highlights emerging treatments for glioblastoma multiforme

Cannabis-derived nanovesicles showed early antitumor potential in mice

Advancing intracellular delivery with LumiPore®: A new approach to cell transfection and drug discovery

The role of UV-Vis in biopharma QC

Galápagos wastewater is creating new reservoirs of antibiotic-resistant bacteria

Tire microplastics could fuel antibiotic resistance in urban environments

New genetic screening method unlocks insights into human development

Single DNA injection provides long-lasting weight loss in mouse study

Quest Diagnostics study uncovers widespread community reservoirs of deadly gut bacterium

Sino Biological’s Cell-Free Protein Synthesis supports Tencent AI for Life Sciences Lab’s protein design study published in Nature Communications

Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit, accelerating AI-powered high-throughput antibody drug discovery

MIDAS platform accelerates protein engineering through rapid PCR-based screening

4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK

Addgene reinforces its expanding role in research with new brand

Kenyan bat coronavirus uses human CEACAM6 to enter cells, raising spillover concerns

DNASE1L2 identified as a dynamic biomarker for TB progression

Novel microneedle patch accelerates healing of chronic diabetic wounds using light

4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer

Neutral polymer enables safer DNA delivery into cells

How the CDC prepares influenza vaccines for pandemics

Mastering plasmid production for genetic engineering and therapeutic research eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics